Innovate outlines filings for more than 60 new spectrum licenses while DBM holds $1.8B adjusted backlog (NYSE:VATE)

INNOVATE (VATE) Q1 2026 earnings call recap: revenue, adjusted EBITDA, $1.8B backlog, MediBeacon progress, Spectrum plans & debt risks—read now.

Read on WOBR AI →